Kavera and Creyos are both digital cognitive/behavioral assessment platforms used by specialty medical practices, but they target different clinical workflows: Creyos centers on standardized cognitive testing and neurobehavioral status exam support (CPT 96116/96132), while Kavera centers on concussion, mental health, cognitive health, and headache monitoring between visits, built around Remote Therapeutic Monitoring (CPT/HCPCS 98975–98981) alongside neurocognitive testing codes.
Who Each Platform Is Built For
Creyos, formerly Cambridge Brain Sciences, markets to a broad multi-segment buyer base: neurologists, psychiatrists, occupational therapists, primary care practices (including senior-focused clinics), health systems and large physician groups, Medicare Advantage payers, and academic researchers. Its core product is a set of automated online cognitive tasks (measuring domains like short-term memory, reasoning, and concentration) paired with standard behavioral-health questionnaires (PHQ-9, GAD-7, PCL-5, ASRS) and condition-specific protocols such as dementia and ADHD screening, according to Creyos's own site (opens in a new tab).
Kavera is built for practices that already see post-injury and post-concussion patients: neurologists, neurosurgeons, orthopedists, sports-medicine physicians, and nurse practitioners. Rather than a general-purpose cognitive testing library aimed at many specialties, Kavera organizes its content around four clinical modules — Concussion, Mental Health, Cognitive Health, and Headache — reflecting the comorbidity pattern common in post-injury care rather than a single-domain screening tool.
Assessment Approach
Creyos's cognitive tasks are gamified, computer-adaptive exercises designed to be taken independently and scored automatically, supplemented by standard behavioral questionnaires layered on top. This is a strength for rapid, repeatable cognitive screening across a wide population.
Kavera uses a assessment battery spanning symptom scales, mood/anxiety/PTSD screens, sleep measures, and cognitive-domain tests, delivered to patients between visits. The battery is organized to generate the kind of structured, timestamped monitoring data that RTM and neurocognitive testing documentation typically requires — administration dates, patient-reported symptom trend lines, and domain-level cognitive results a clinician can review at the next encounter. See individual instrument pages such as PCSS, PHQ-9, and PCL-5 for detail on what each measure covers.
Billing and Documentation Content
Both companies publish clinical/billing education content, but the code focus differs. Creyos has published articles differentiating CPT 96125, 96116, and 96132/96133, walking through worked scenarios for mental-health workups, technician-administered testing in neurology practices, and primary-care pre-screening (see Creyos's CPT code articles (opens in a new tab)). Creyos also markets that its auto-generated reports simplify claims documentation and that combined cognitive/behavioral data can help support medical necessity.
Kavera's billing content centers heavily on Remote Therapeutic Monitoring — CPT/HCPCS 98975, 98978, 98980, and 98981 — in addition to neurocognitive testing codes such as 96132, 96133, 96136, 96137, 96116, 96121, and 96146. RTM code 98978, which covers device/CBT monitoring supply for between-visit data, is a particular area of focus for Kavera because concussion-care practices already generate the qualifying data through repeated patient check-ins but frequently do not currently bill for it. Public evidence suggests Creyos's billing content does not center on the RTM code family in the same way; this is based on the content published on creyos.com/blog as of this research and should be treated as an observation about published content, not a claim about product capability.
Comparison Table
| Kavera | Creyos | |
|---|---|---|
| Primary clinical focus | Concussion, mental health, cognitive health, headache monitoring | General cognitive testing + behavioral-health screening across specialties |
| Target buyer | Neurology, neurosurgery, ortho, sports medicine, NPs treating post-injury patients | Neurology, psychiatry, OT, primary care, health systems, payers, researchers |
| Assessment structure | assessment battery delivered between visits | Automated cognitive tasks + standard behavioral questionnaires + condition protocols |
| RTM billing focus (98975–98981) | Central to platform positioning, especially 98978 | Publicly unconfirmed as a primary content/product focus |
| Neurocognitive testing code content (96116/96132/96133/96136-39/96146) | Covered across dedicated code pages | Covered, with published articles differentiating 96125/96116/96132 |
| Self-serve plan | Yes | Publicly unconfirmed (no self-serve tier described on creyos.com) |
| Managed/staff-assisted plan | Yes (Managed) | Publicly unconfirmed |
| Public pricing | Not published on either site | Not published; routes to demo request |
| Research/validation claims | Not asserted as a marketing claim | Creyos states "30 years of research" and use in "400+ peer-reviewed studies" (company claim, not independently verified here) |
Where Creyos May Fit Better
Practices whose primary need is broad cognitive screening across many specialties and conditions — not specifically post-injury or concussion care — and that want a single platform spanning primary care, psychiatry, and OT use cases may find Creyos's multi-segment design a closer fit. Its published CPT 96116/96132/96133 differentiation content is also a useful public resource for practices new to those codes generally, independent of which platform they ultimately choose.
Where Kavera May Fit Better
Practices centered on post-concussion, sports-medicine, or specialty follow-up care — where mood, sleep, cognitive, and symptom data need to be tracked together between visits, and where RTM billing (particularly 98978) represents a documentation and revenue opportunity that isn't yet operationalized — are the workflow Kavera is built around. The module structure (Concussion, Mental Health, Cognitive Health, Headache) reflects that comorbidity pattern rather than treating each domain as a standalone screening product.
How Kavera Handles This
Dr. Abrahams used Creyos in his own program before building Kavera. Kavera keeps the cognitive testing and adds what a concussion practice needs around it: the first-visit neuropsych battery, weekly check-ins, brain training, guided support, telehealth, and documentation built for RTM and testing codes. Self-Serve practices run this with their own staff. On Managed, Juliet Mott's team runs it and bills it under your credentials.
FAQ
Is Creyos a concussion-specific platform?
No. Creyos is a general cognitive and behavioral-health assessment platform used across neurology, psychiatry, occupational therapy, and primary care. It is not organized around concussion-specific modules the way Kavera is.
Does Creyos support RTM billing (98975–98981)?
Creyos's publicly available content centers on standardized cognitive testing codes (96125, 96116, 96132/96133) rather than the RTM code family. Whether Creyos's product supports RTM workflows internally is publicly unconfirmed based on the content reviewed for this comparison.
Which platform has published pricing?
Neither Kavera nor Creyos publishes dollar pricing on their marketing sites as of this writing; both route prospects to a demo or sales conversation.
Can a practice use both types of tools?
Some practices use general cognitive screening tools alongside a concussion-specific monitoring workflow, though duplicating overlapping domains (e.g., running two separate cognitive batteries) is generally inefficient and can complicate documentation. Practices should evaluate based on their primary patient population and billing goals.
Where should I start if I'm new to RTM billing?
See RTM for Cognitive-Behavioral Monitoring and the 98978 code page for an overview, and consult current CMS (opens in a new tab) guidance before billing.
See this on your own patient population
One field. 30 minutes. Live demo with a clinician.